Eri Kato
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes Treatment and Management 14
- Diabetes Management and Research 4
- Nephrology top 1%
-
- Atrial Fibrillation Management and Outcomes 4
- Heart Failure Treatment and Management 4
- Surgery top 1%
- Pancreatic function and diabetes 4
- Pharmacology top 1%
-
- Metabolism, Diabetes, and Cancer 6
-
- Systemic Lupus Erythematosus Research 5
- Rheumatoid Arthritis Research and Therapies 5
- Co-authors
- Marc S. SabatineDarren K. McGuireMarc P. BonacaOfri MosenzonDeepak L. BhattJohn WildingAvivit CahnLawrence A. Leiter
- Journals
- Circulation (3 papers)Journal of the American Heart Association (2 papers)European Heart Journal - Cardiovascular Pharmacotherapy (2 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Eri Kato
44 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Endocrinology, Diabetes and Metabolism 6.0k
- Nephrology 657
- Cardiology and Cardiovascular Medicine 2.0k
- Surgery 2.5k
- Pharmacology 670
Countries citing papers authored by Eri Kato
This map shows the geographic impact of Eri Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri Kato more than expected).
Fields of papers citing papers by Eri Kato
This network shows the impact of papers produced by Eri Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri Kato. The network helps show where Eri Kato may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eri Kato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 8 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 17 | |
| 12 | 2020 | 8 | |
| 13 | Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitusbreakdown → | 2019 | 534 |
| 14 | 2019 | 29 | |
| 15 | SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trialsbreakdown → | 2018 | 1897 |
| 16 | 2018 | 5 | |
| 17 | 2018 | 1 | |
| 18 | 2018 | 121 | |
| 19 | 2018 | 36 | |
| 20 | 2017 | 3 |
About Eri Kato
Eri Kato is a scholar working on Endocrinology, Diabetes and Metabolism, Rheumatology and Cardiology and Cardiovascular Medicine, having authored 47 papers that have together received 7.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (14 papers), Metabolism, Diabetes, and Cancer (6 papers), Systemic Lupus Erythematosus Research (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers), Atrial Fibrillation Management and Outcomes (4 papers), Diabetes Management and Research (4 papers), Heart Failure Treatment and Management (4 papers) and Pancreatic function and diabetes (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (6.0k citations), Nephrology (657 citations) and Cardiology and Cardiovascular Medicine (2.0k citations). Eri Kato has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Marc S. Sabatine, Darren K. McGuire, Marc P. Bonaca, Ofri Mosenzon, Deepak L. Bhatt, John Wilding, Avivit Cahn, Lawrence A. Leiter, Stephen D. Wiviott and Thomas A. Zelniker. Their work appears in journals such as Circulation, Journal of the American Heart Association, European Heart Journal - Cardiovascular Pharmacotherapy, Solid State Ionics and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.